One-Year Outcomes of Low-Dose Bevacizumab for ROP
Reticular Pseudodrusen Is a Key Risk Factor for Late AMD
Computer Vision Syndrome: Current Management Is Inadequate
Corneal Hysteresis and Rates of Neuroretinal Rim Change
Initial Observation for Idiopathic Vitreomacular Traction
New Tool to Detect Glaucoma in Eyes With High Axial Myopia
Racial Disparities in Glaucoma Severity and Monitoring
Ocular Adverse Events Related to Taxane-Based Drugs
Metastasis-Free Survival in Uveal Melanoma
Association of Industry Payments With Glaucoma Eyedrop Prescribing Patterns
Social Media’s Role for Ophthalmologists
Drusen Characteristics As a Potential Genetic Marker for AMD
All content on the Academy’s website is protected by copyright law and the Terms of Service. This content may not be reproduced, copied, or put into any artificial intelligence program, including large language and generative AI models, without permission from the Academy.